IZOTROPIC CORP.
Research IZOTROPIC CORP. (1R3) on Bullrun: market cap EUR 9.08M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1R3
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 9.08M
- Financial periodQ1 2026
- RevenueCAD 0
- Net income-CAD 262.11K
- Free cash flow-CAD 157.22K
Valuation Snapshot
latest market cap is EUR 9.08M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 9.08M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About IZOTROPIC CORP.
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a breast CT imaging system. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is IZOTROPIC CORP.'s market cap?
IZOTROPIC CORP.'s market capitalization is EUR 9.08M.
What does IZOTROPIC CORP. do?
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a breast CT imaging system. The company was incorporated in 2016 and is headquartered in Surrey, Canada.